{
  "DOI": "10.1038/s41431-023-01426-5",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-023-01426-5",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eNeurofibromatosis 1 (NF1) is a multisystem disorder associated with, for example, a high risk for cancer, a variety of behavioral and cognitive deficits, low educational attainment and decreased income. We now examined the labor market participation of individuals with NF1. We analyzed the numbers of days of work, unemployment, and sickness allowance among 742 Finnish individuals with NF1 aged 20–59 years using nationwide register data from Statistics Finland and the Social Insurance Institution of Finland. The individuals with NF1 were compared with a control cohort of 8716 individuals matched with age, sex, and the area of residence. Individuals with NF1 had a significantly lower number of working days per year than the controls (rate ratio [RR] 0.93, 95% CI 0.91–0.95). Unemployment (RR 1.79, 95% CI 1.58–2.02), and sickness absence (RR 1.44, 95% CI 1.25–1.67) were more frequent in the NF1 than in the control group. The causes of sickness allowances were highly concordant with the previously reported morbidity profile of NF1 including neoplasms, cardiovascular disease, mental and behavioral diseases, and neurological diseases. In conclusion, NF1 significantly interferes with labor market participation \u003cjats:italic\u003evia\u003c/jats:italic\u003e both unemployment and morbidity. Unemployment seems to cause more days of not working than sickness absence.\u003c/jats:p\u003e",
  "alternative-id": [
    "1426"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "13 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "24 May 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "29 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "18 July 2023"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Ethics approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The Ethics Committee of the Hospital District of Southwest Finland approved the study. Research permissions were obtained from the Finnish Institute for Health and Welfare, the Social Insurance Institution of Finland, the Finnish Population Register Centre, Statistics Finland, and all participating hospitals. The study followed the principles of the Declaration of Helsinki. The study was register-based and retrospective and therefore exempt from obtaining informed consent from the participants. All analyses were carried out using pseudonymized data."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-7512-2980",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kallionpää",
      "given": "Roope A.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Johansson",
      "given": "Edvard",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5372-2985",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Böckerman",
      "given": "Petri",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5732-4167",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Peltonen",
      "given": "Juha",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-0990-1430",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Peltonen",
      "given": "Sirkku",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        7,
        18
      ]
    ],
    "date-time": "2023-07-18T03:30:37Z",
    "timestamp": 1689651037000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        1,
        8
      ]
    ],
    "date-time": "2024-01-08T00:04:20Z",
    "timestamp": 1704672260000
  },
  "funder": [
    {
      "DOI": "10.13039/501100010711",
      "doi-asserted-by": "publisher",
      "name": "Syöpäsäätiö"
    },
    {
      "DOI": "10.13039/501100011797",
      "doi-asserted-by": "publisher",
      "name": "Turun Yliopistollinen Keskussairaala"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        8
      ]
    ],
    "date-time": "2024-01-08T05:08:43Z",
    "timestamp": 1704690523999
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        7,
        18
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2024,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            7,
            18
          ]
        ],
        "date-time": "2023-07-18T00:00:00Z",
        "timestamp": 1689638400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            7,
            18
          ]
        ],
        "date-time": "2023-07-18T00:00:00Z",
        "timestamp": 1689638400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-023-01426-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-023-01426-5",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-023-01426-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "83-90",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2023,
        7,
        18
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        7,
        18
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2024,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/jid.2014.465",
      "author": "E Uusitalo",
      "doi-asserted-by": "publisher",
      "first-page": "904",
      "journal-title": "J Invest Dermatol",
      "key": "1426_CR1",
      "unstructured": "Uusitalo E, Leppävirta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol. 2015;135:904–6.",
      "volume": "135",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2017.215",
      "author": "RA Kallionpää",
      "doi-asserted-by": "publisher",
      "first-page": "1082",
      "journal-title": "Genet Med",
      "key": "1426_CR2",
      "unstructured": "Kallionpää RA, Uusitalo E, Leppävirta J, Pöyhönen M, Peltonen S, Peltonen J. Prevalence of neurofibromatosis type 1 in the Finnish population. Genet Med. 2018;20:1082–6.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1126/science.2134734",
      "author": "MR Wallace",
      "doi-asserted-by": "publisher",
      "first-page": "181",
      "journal-title": "Science",
      "key": "1426_CR3",
      "unstructured": "Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, et al. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science. 1990;249:181–6.",
      "volume": "249",
      "year": "1990"
    },
    {
      "DOI": "10.1016/0092-8674(90)90024-9",
      "author": "G Xu",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Cell",
      "key": "1426_CR4",
      "unstructured": "Xu G, O’Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990;62:599–608.",
      "volume": "62",
      "year": "1990"
    },
    {
      "DOI": "10.1001/archneur.1988.00520290115023",
      "author": "National Institutes of Health Consensus Development Conference.",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "journal-title": "Arch Neurol",
      "key": "1426_CR5",
      "unstructured": "National Institutes of Health Consensus Development Conference. Neurofibromatosis. Conference statement. Arch Neurol. 1988;45:575–8.",
      "volume": "45",
      "year": "1988"
    },
    {
      "DOI": "10.1038/s41436-021-01170-5",
      "author": "E Legius",
      "doi-asserted-by": "publisher",
      "first-page": "1506",
      "journal-title": "Genet Med",
      "key": "1426_CR6",
      "unstructured": "Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23:1506–13.",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ajpath.2010.12.056",
      "author": "EM Jouhilahti",
      "doi-asserted-by": "publisher",
      "first-page": "1932",
      "journal-title": "Am J Pathol",
      "key": "1426_CR7",
      "unstructured": "Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011;178:1932–9.",
      "volume": "178",
      "year": "2011"
    },
    {
      "DOI": "10.1186/s13023-018-0772-z",
      "author": "A Cannon",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "1426_CR8",
      "unstructured": "Cannon A, Chen M-J, Li P, Boyd KP, Theos A, Redden DT, et al. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study. Orphanet J Rare Dis. 2018;13:31.",
      "volume": "13",
      "year": "2018"
    },
    {
      "DOI": "10.1212/WNL.0000000000005792",
      "author": "N Ortonne",
      "doi-asserted-by": "publisher",
      "first-page": "S5",
      "journal-title": "Neurology",
      "key": "1426_CR9",
      "unstructured": "Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, et al. Cutaneous neurofibromas: current clinical and pathologic issues. Neurology. 2018;91:S5–S13.",
      "volume": "91",
      "year": "2018"
    },
    {
      "DOI": "10.1159/000187594",
      "author": "Y Kodra",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "journal-title": "Dermatology",
      "key": "1426_CR10",
      "unstructured": "Kodra Y, Giustini S, Divona L, Porciello R, Calvieri S, Wolkenstein P, et al. Health-related quality of life in patients with neurofibromatosis type 1: A survey of 129 Italian patients. Dermatology. 2009;218:215–20.",
      "volume": "218",
      "year": "2009"
    },
    {
      "DOI": "10.1159/000337548",
      "author": "S Granström",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Dermatology",
      "key": "1426_CR11",
      "unstructured": "Granström S, Langenbruch A, Augustin M, Mautner V-F. Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image. Dermatology. 2012;224:160–7.",
      "volume": "224",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s13023-019-1265-4",
      "author": "M Guiraud",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "1426_CR12",
      "unstructured": "Guiraud M, Bouroubi A, Beauchamp R, Bocquet A, Grégoire J-M, Rauly-Lestienne I, et al. Cutaneous neurofibromas: patients’ medical burden, current management and therapeutic expectations: results from an online European patient community survey. Orphanet J Rare Dis. 2019;14:286.",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1016/S1474-4422(07)70075-3",
      "author": "RE Ferner",
      "doi-asserted-by": "publisher",
      "first-page": "340",
      "journal-title": "Lancet Neurol",
      "key": "1426_CR13",
      "unstructured": "Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007;6:340–51.",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ajmg.a.37123",
      "author": "PL Wolters",
      "doi-asserted-by": "publisher",
      "first-page": "2103",
      "journal-title": "Am J Med Genet Part A",
      "key": "1426_CR14",
      "unstructured": "Wolters PL, Burns KM, Martin S, Baldwin A, Dombi E, Toledo-Tamula MA, et al. Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life. Am J Med Genet Part A. 2015;167:2103–13.",
      "volume": "167",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2018.28",
      "author": "DR Stewart",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "journal-title": "Genet Med.",
      "key": "1426_CR15",
      "unstructured": "Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20:671–82.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2015.65.3576",
      "author": "E Uusitalo",
      "doi-asserted-by": "publisher",
      "first-page": "1978",
      "journal-title": "J Clin Oncol",
      "key": "1426_CR16",
      "unstructured": "Uusitalo E, Rantanen M, Kallionpää RA, Pöyhönen M, Leppävirta J, Ylä-Outinen H, et al. Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol. 2016;34:1978–86.",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1038/sj.bjc.6603227",
      "author": "L Walker",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "journal-title": "Br J Cancer",
      "key": "1426_CR17",
      "unstructured": "Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer. 2006;95:233–8.",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1038/bjc.2012.535",
      "author": "OO Seminog",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "journal-title": "Br J Cancer",
      "key": "1426_CR18",
      "unstructured": "Seminog OO, Goldacre MJ. Risk of benign tumours of nervous system and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer. 2013;108:193–8.",
      "volume": "108",
      "year": "2013"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2021.0945",
      "author": "JP Landry",
      "doi-asserted-by": "publisher",
      "first-page": "e210945",
      "journal-title": "JAMA Netw open",
      "key": "1426_CR19",
      "unstructured": "Landry JP, Schertz KL, Chiang Y-J, Bhalla AD, Yi M, Keung EZ, et al. Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Netw open. 2021;4:e210945.",
      "volume": "4",
      "year": "2021"
    },
    {
      "DOI": "10.1002/ajmg.a.33045",
      "author": "F Elefteriou",
      "doi-asserted-by": "publisher",
      "first-page": "2327",
      "journal-title": "Am J Med Genet A",
      "key": "1426_CR20",
      "unstructured": "Elefteriou F, Kolanczyk M, Schindeler A, Viskochil DH, Hock JM, Schorry EK, et al. Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A. 2009;149A:2327–38.",
      "volume": "149A",
      "year": "2009"
    },
    {
      "DOI": "10.1002/jbmr.1685",
      "author": "E Heervä",
      "doi-asserted-by": "publisher",
      "first-page": "2333",
      "journal-title": "J Bone Min Res",
      "key": "1426_CR21",
      "unstructured": "Heervä E, Koffert A, Jokinen E, Kuorilehto T, Peltonen S, Aro HT, et al. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age. J Bone Min Res. 2012;27:2333–7.",
      "volume": "27",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ajmg.a.61069",
      "author": "AM Kongkriangkai",
      "doi-asserted-by": "publisher",
      "first-page": "602",
      "journal-title": "Am J Med Genet A",
      "key": "1426_CR22",
      "unstructured": "Kongkriangkai AM, King C, Martin LJ, Wakefield E, Prada CE, Kelly-Mancuso G, et al. Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1. Am J Med Genet A. 2019;179:602–7.",
      "volume": "179",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41436-020-0769-6",
      "author": "L Kenborg",
      "doi-asserted-by": "publisher",
      "first-page": "1069",
      "journal-title": "Genet Med",
      "key": "1426_CR23",
      "unstructured": "Kenborg L, Duun-Henriksen AK, Dalton SO, Bidstrup PE, Doser K, Rugbjerg K, et al. Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span. Genet Med. 2020;22:1069–78.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41436-021-01261-3",
      "author": "RA Kallionpää",
      "doi-asserted-by": "publisher",
      "first-page": "2219",
      "journal-title": "Genet Med",
      "key": "1426_CR24",
      "unstructured": "Kallionpää RA, Valtanen M, Auranen K, Uusitalo E, Rinne JO, Peltonen S, et al. Increased risk for dementia in neurofibromatosis type 1. Genet Med. 2021;23:2219–22.",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1086/320121",
      "author": "SA Rasmussen",
      "doi-asserted-by": "publisher",
      "first-page": "1110",
      "journal-title": "Am J Hum Genet",
      "key": "1426_CR25",
      "unstructured": "Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001;68:1110–8.",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmedgenet-2011-100562",
      "author": "A Wilding",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "journal-title": "J Med Genet",
      "key": "1426_CR26",
      "unstructured": "Wilding A, Ingham SL, Lalloo F, Clancy T, Huson SM, Moran A, et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet. 2012;49:264–9.",
      "volume": "49",
      "year": "2012"
    },
    {
      "DOI": "10.1177/0883073808316366",
      "author": "LC Krab",
      "doi-asserted-by": "publisher",
      "first-page": "1002",
      "journal-title": "J Child Neurol",
      "key": "1426_CR27",
      "unstructured": "Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, et al. Impact of neurofibromatosis type 1 on school performance. J Child Neurol. 2008;23:1002–10.",
      "volume": "23",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ajmg.a.33178",
      "author": "L Alivuotila",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "journal-title": "Am J Med Genet Part A",
      "key": "1426_CR28",
      "unstructured": "Alivuotila L, Hakokari J, Visnapuu V, Korpijaakko-Huuhka AM, Aaltonen O, Happonen RP, et al. Speech characteristics in neurofibromatosis type 1. Am J Med Genet Part A. 2010;152:42–51.",
      "volume": "152",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1365-2788.2012.01648.x",
      "author": "MJ Descheemaeker",
      "doi-asserted-by": "publisher",
      "first-page": "874",
      "journal-title": "J Intellect Disabil Res",
      "key": "1426_CR29",
      "unstructured": "Descheemaeker MJ, Plasschaert E, Frijns JP, Legius E. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group. J Intellect Disabil Res. 2013;57:874–86.",
      "volume": "57",
      "year": "2013"
    },
    {
      "DOI": "10.1111/dmcn.12734",
      "author": "A Lehtonen",
      "doi-asserted-by": "publisher",
      "first-page": "645",
      "journal-title": "Dev Med Child Neurol",
      "key": "1426_CR30",
      "unstructured": "Lehtonen A, Garg S, Roberts SA, Trump D, Evans DG, Green J, et al. Cognition in children with neurofibromatosis type 1: data from a population-based study. Dev Med Child Neurol. 2015;57:645–51.",
      "volume": "57",
      "year": "2015"
    },
    {
      "DOI": "10.1177/1087054712450749",
      "author": "VF Mautner",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "J Atten Disord",
      "key": "1426_CR31",
      "unstructured": "Mautner VF, Granström S, Leark RA. Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems. J Atten Disord. 2015;19:35–43.",
      "volume": "19",
      "year": "2015"
    },
    {
      "DOI": "10.1002/ajmg.b.32414",
      "author": "E Plasschaert",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Am J Med Genet Part B Neuropsychiatr Genet",
      "key": "1426_CR32",
      "unstructured": "Plasschaert E, Van Eylen L, Descheemaeker MJ, Noens I, Legius E, Steyaert J. Executive functioning deficits in children with neurofibromatosis type 1: the influence of intellectual and social functioning. Am J Med Genet Part B Neuropsychiatr Genet. 2016;171:348–62.",
      "volume": "171",
      "year": "2016"
    },
    {
      "DOI": "10.1111/dmcn.13526",
      "author": "AC Vogel",
      "doi-asserted-by": "publisher",
      "first-page": "1112",
      "journal-title": "Dev Med Child Neurol.",
      "key": "1426_CR33",
      "unstructured": "Vogel AC, Gutmann DH, Morris SM. Neurodevelopmental disorders in children with neurofibromatosis type 1. Dev Med Child Neurol. 2017;59:1112–6.",
      "volume": "59",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41436-020-0752-2",
      "author": "MJ Ottenhoff",
      "doi-asserted-by": "publisher",
      "first-page": "889",
      "journal-title": "Genet Med",
      "key": "1426_CR34",
      "unstructured": "Ottenhoff MJ, Rietman AB, Mous SE, Plasschaert E, Gawehns D, Brems H, et al. Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. Genet Med. 2020;22:889–97.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1111/cge.13907",
      "author": "E Johansson",
      "doi-asserted-by": "publisher",
      "first-page": "529",
      "journal-title": "Clin Genet",
      "key": "1426_CR35",
      "unstructured": "Johansson E, Kallionpää RA, Böckerman P, Peltonen J, Peltonen S. A rare disease and education: neurofibromatosis type 1 decreases educational attainment. Clin Genet. 2021;99:529–39.",
      "volume": "99",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41431-019-0359-8",
      "author": "K Doser",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "journal-title": "Eur J Hum Genet",
      "key": "1426_CR36",
      "unstructured": "Doser K, Kenborg L, Andersen EW, Bidstrup PE, Kroyer A, Hove H, et al. Educational delay and attainment in persons with neurofibromatosis 1 in Denmark. Eur J Hum Genet. 2019;27:857–68.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jpsychires.2021.06.002",
      "author": "M-M Geoffray",
      "doi-asserted-by": "publisher",
      "first-page": "545",
      "journal-title": "J Psychiatr Res",
      "key": "1426_CR37",
      "unstructured": "Geoffray M-M, Robinson L, Ramamurthy K, Manderson L, O’Flaherty J, Lehtonen A, et al. Predictors of cognitive, behavioural and academic difficulties in NF1. J Psychiatr Res. 2021;140:545–50.",
      "volume": "140",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.gim.2021.11.024",
      "author": "E Johansson",
      "doi-asserted-by": "publisher",
      "first-page": "870",
      "journal-title": "Genet Med",
      "key": "1426_CR38",
      "unstructured": "Johansson E, Kallionpää RA, Böckerman P, Peltonen S, Peltonen J. The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland. Genet Med. 2022;24:870–9.",
      "volume": "24",
      "year": "2022"
    },
    {
      "DOI": "10.1186/s13023-021-01866-6",
      "author": "FD Buono",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "1426_CR39",
      "unstructured": "Buono FD, Sprong ME, Paul E, Martin S, Larkin K, Garakani A. The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1. Orphanet J Rare Dis. 2021;16:234.",
      "volume": "16",
      "year": "2021"
    },
    {
      "DOI": "10.1038/gim.2014.70",
      "author": "CC Madubata",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Genet Med",
      "key": "1426_CR40",
      "unstructured": "Madubata CC, Olsen MA, Stwalley DL, Gutmann DH, Johnson KJ. Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis. Genet Med. 2015;17:36–42.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1002/ajmg.a.38372",
      "author": "J Leppävirta",
      "doi-asserted-by": "publisher",
      "first-page": "2641",
      "journal-title": "Am J Med Genet Part A",
      "key": "1426_CR41",
      "unstructured": "Leppävirta J, Kallionpää RA, Uusitalo E, Vahlberg T, Pöyhönen M, Timonen S, et al. The pregnancy in neurofibromatosis 1: a retrospective register-based total population study. Am J Med Genet Part A. 2017;173:2641–8.",
      "volume": "173",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ajog.2013.03.029",
      "author": "AR Terry",
      "doi-asserted-by": "publisher",
      "first-page": "46.e1",
      "journal-title": "Am J Obstet Gynecol",
      "key": "1426_CR42",
      "unstructured": "Terry AR, Barker FG, Leffert L, Bateman BT, Souter I, Plotkin SR. Neurofibromatosis type 1 and pregnancy complications: a population-based study. Am J Obstet Gynecol. 2013;209:46.e1–8.",
      "volume": "209",
      "year": "2013"
    },
    {
      "DOI": "10.1093/bmb/ldp033",
      "author": "IJ Deary",
      "doi-asserted-by": "publisher",
      "first-page": "135",
      "journal-title": "Br Med Bull",
      "key": "1426_CR43",
      "unstructured": "Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, et al. Age-associated cognitive decline. Br Med Bull. 2009;92:135–52.",
      "volume": "92",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2022.49568",
      "author": "F Vergunst",
      "doi-asserted-by": "publisher",
      "first-page": "e2249568",
      "journal-title": "JAMA Netw open",
      "key": "1426_CR44",
      "unstructured": "Vergunst F, Commisso M, Geoffroy M-C, Temcheff C, Poirier M, Park J, et al. Association of childhood externalizing, internalizing, and comorbid symptoms with long-term economic and social outcomes. JAMA Netw open. 2023;6:e2249568.",
      "volume": "6",
      "year": "2023"
    },
    {
      "DOI": "10.1038/nrdp.2017.4",
      "author": "DH Gutmann",
      "doi-asserted-by": "publisher",
      "first-page": "17004",
      "journal-title": "Nat Rev Dis Prim",
      "key": "1426_CR45",
      "unstructured": "Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Prim. 2017;3:17004.",
      "volume": "3",
      "year": "2017"
    }
  ],
  "reference-count": 45,
  "references-count": 45,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-023-01426-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "32"
}